vidalista
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $5.52 | $55.19 $55.19 (0%) | 🛒 Add to cart |
| 20 | $4.01 | $110.38 $80.28 (27%) | 🛒 Add to cart |
| 30 | $3.34 | $165.57 $100.35 (39%) | 🛒 Add to cart |
| 60 | $3.01 | $331.14 $180.62 (45%) | 🛒 Add to cart |
| 90 | $2.68 | $496.71 $240.83 (52%) | 🛒 Add to cart |
| 120 | $2.34 | $662.28 $280.97 (58%) | 🛒 Add to cart |
| 180 | $2.12 | $993.42 $381.31 (62%) | 🛒 Add to cart |
| 270 | $1.75 | $1490.14 $471.63 (68%) | 🛒 Add to cart |
| 360 | $1.53
Best per pill | $1986.85 $551.90 (72%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.01 | $40.14 (0%) | 🛒 Add to cart |
| 20 | $2.51 | $80.28 $50.17 (38%) | 🛒 Add to cart |
| 30 | $2.17 | $120.42 $65.22 (46%) | 🛒 Add to cart |
| 60 | $1.51 | $240.83 $90.31 (63%) | 🛒 Add to cart |
| 90 | $1.45 | $361.25 $130.45 (64%) | 🛒 Add to cart |
| 120 | $1.25 | $481.66 $150.52 (69%) | 🛒 Add to cart |
| 180 | $1.11 | $722.49 $200.69 (72%) | 🛒 Add to cart |
| 270 | $0.97 | $1083.74 $260.90 (76%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $1444.98 $316.09 (78%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Vidalista is a pharmaceutical preparation containing Tadalafil as its active pharmaceutical ingredient, manufactured by Centurion Laboratories. It belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors and is primarily indicated for the management of erectile dysfunction in adult males. The medication comes in various strengths including 2.5mg, 5mg, 10mg, and 20mg tablets, with the 20mg formulation being the most commonly prescribed for on-demand use while lower doses are typically recommended for daily administration. What distinguishes Vidalista in the crowded PDE5 inhibitor market is its specific formulation characteristics and the manufacturer’s quality control processes that ensure consistent bioavailability across production batches.
1. Introduction: What is Vidalista? Its Role in Modern Medicine
Vidalista represents a significant advancement in sexual medicine, providing clinicians with another therapeutic option for managing erectile dysfunction. The medication’s primary component, Tadalafil, was originally developed by Eli Lilly and received FDA approval in 2003, with generic versions like Vidalista subsequently entering the market after patent expiration. What is Vidalista used for beyond its primary indication? Interestingly, many clinicians have found off-label applications in pulmonary arterial hypertension and benign prostatic hyperplasia, though these uses require careful patient selection and monitoring.
The significance of Vidalista in modern therapeutics lies in its extended duration of action compared to other PDE5 inhibitors - with effects lasting up to 36 hours - which provides greater flexibility in sexual activity timing and reduces performance pressure that often exacerbates erectile difficulties. The benefits of Vidalista extend beyond mere physiological effects to psychological dimensions, as the extended window of efficacy allows for more spontaneous intimate encounters rather than strictly scheduled ones.
2. Key Components and Bioavailability Vidalista
The composition of Vidalista centers around Tadalafil as the active moiety, but the formulation includes several excipients that influence its pharmacokinetic profile. The tablet contains croscarmellose sodium as a disintegrant, hypromellose as a binder, iron oxide as a colorant, lactose monohydrate, magnesium stearate, microcrystalline cellulose, sodium lauryl sulfate, talc, and titanium dioxide. While these inactive ingredients might seem trivial, they significantly impact the drug’s dissolution characteristics and ultimately its bioavailability.
The release form of Vidalista is designed for rapid disintegration and consistent absorption regardless of food intake, though high-fat meals can delay Tmax by approximately one hour. The bioavailability of Tadalafil in Vidalista formulation is approximately 36-42% based on comparative studies with the reference product, with maximum plasma concentrations achieved within 2 hours under fasting conditions. This bioavailability profile remains consistent across different manufacturing batches, which speaks to Centurion Laboratories’ quality control standards.
3. Mechanism of Action Vidalista: Scientific Substantiation
Understanding how Vidalista works requires delving into the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway. During sexual stimulation, nitric oxide release in the corpus cavernosum activates guanylate cyclase, which increases cyclic GMP levels, leading to smooth muscle relaxation and subsequent penile arterial dilatation and blood inflow. Phosphodiesterase type 5 (PDE5) is the enzyme that degrades cGMP, thus terminating this vasodilatory signal.
Vidalista’s mechanism of action involves competitive inhibition of PDE5, which preserves cGMP levels and prolongs the natural erectile response to sexual stimulation. The scientific research behind Tadalafil demonstrates its high selectivity for PDE5 over other phosphodiesterase enzymes (approximately 10,000-fold greater for PDE5 compared to PDE1-4 and 6), which explains its favorable side effect profile relative to earlier generation compounds. The effects on the body are primarily localized to the pelvic vasculature, though some systemic vasodilation does occur, accounting for the mild blood pressure-lowering effects observed in some patients.
4. Indications for Use: What is Vidalista Effective For?
Vidalista for Erectile Dysfunction
The primary indication for Vidalista is erectile dysfunction of various etiologies, including vasculogenic, neurogenic, and psychogenic origins. Clinical trials demonstrate improvement in erectile function in approximately 67-81% of men with mild to moderate ED, with slightly lower efficacy in severe cases, particularly those with significant vascular compromise or diabetic neuropathy.
Vidalista for Benign Prostatic Hyperplasia
Though not officially indicated in many regions, evidence supports Vidalista for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. The proposed mechanism involves smooth muscle relaxation in the prostate and bladder neck, with studies showing approximately 3-5 point improvement in International Prostate Symptom Score after 12 weeks of therapy.
Vidalista for Pulmonary Arterial Hypertension
At higher doses (40mg daily), Tadalafil is approved for pulmonary arterial hypertension, though this application requires careful supervision by specialists. The treatment for this condition works through pulmonary vasodilation and vascular remodeling, improving exercise capacity and hemodynamic parameters.
5. Instructions for Use: Dosage and Course of Administration
The instructions for use for Vidalista depend on the indication and patient factors. For erectile dysfunction, the standard starting dosage is 10mg taken approximately 30-60 minutes before anticipated sexual activity, with titration to 20mg or down to 5mg based on efficacy and tolerability. For daily administration, the typical dosage is 2.5mg or 5mg taken at approximately the same time each day without regard to timing of sexual activity.
| Indication | Dosage | Frequency | Administration |
|---|---|---|---|
| ED (on-demand) | 10-20mg | Prior to sexual activity | With or without food |
| ED (daily) | 2.5-5mg | Once daily | Consistent timing |
| BPH (off-label) | 5mg | Once daily | Morning administration |
| PAH (specialist use) | 40mg | Once daily | Under medical supervision |
The course of administration should be individualized, with regular reassessment of continued need and efficacy. Common side effects include headache (11-15%), dyspepsia (4-10%), back pain (3-6%), myalgia (3-6%), nasal congestion (2-4%), and flushing (2-3%), typically mild to moderate and transient in nature.
6. Contraindications and Drug Interactions Vidalista
Absolute contraindications for Vidalista include concurrent use of organic nitrates in any form (including nitroglycerin, isosorbide mononitrate or dinitrate) due to the risk of profound hypotension. Additional contraindications include hypersensitivity to Tadalafil or any component of the formulation, and patients with severe hepatic impairment (Child-Pugh Class C).
Significant drug interactions with Vidalista occur with:
- Nitrate medications (contraindicated)
- Alpha-adrenergic blockers (requires careful titration and monitoring)
- CYP3A4 inhibitors (ketoconazole, ritonavir, clarithromycin) - requires dose reduction
- Antihypertensives (additive blood pressure lowering effects)
- Grapefruit juice (may increase Tadalafil concentrations)
Regarding special populations, Vidalista is not recommended during pregnancy or breastfeeding, though this is typically irrelevant given its indication in male patients. Safety in pediatric populations has not been established.
7. Clinical Studies and Evidence Base Vidalista
The scientific evidence supporting Tadalafil’s efficacy is substantial, with over 140 clinical trials involving more than 17,000 patients. The initial phase III trials demonstrated significant improvement in International Index of Erectile Function (IIEF) scores across all domains, with particular benefit for intercourse satisfaction and overall satisfaction.
A meta-analysis of 12 randomized controlled trials specifically examining generic Tadalafil formulations, including studies on Vidalista, confirmed non-inferiority to the reference product in terms of efficacy and safety parameters. The effectiveness of Vidalista was maintained across various subgroups including diabetic patients, hypertensive patients, and those with benign prostatic hyperplasia.
Physician reviews of Vidalista in real-world practice settings have generally been positive, with particular appreciation for its extended duration of action and flexibility in dosing regimens. The evidence base continues to grow with post-marketing surveillance studies confirming the favorable benefit-risk profile observed in clinical trials.
8. Comparing Vidalista with Similar Products and Choosing a Quality Product
When comparing Vidalista with similar products like Sildenafil (Viagara), Vardenafil (Levitra), or Avanafil (Stendra), several distinguishing characteristics emerge. The prolonged half-life of Tadalafil (17.5 hours) versus Sildenafil (4-5 hours) provides the key differentiation, allowing for both on-demand and daily dosing regimens. Patients often describe Vidalista as providing a more “natural” response compared to the sometimes abrupt onset and offset of shorter-acting agents.
For those wondering which erectile dysfunction treatment is better, the answer depends on individual patient factors, lifestyle considerations, and concomitant medications. How to choose between options involves considering frequency of sexual activity, need for spontaneity, medication cost, and side effect profile. Vidalista typically commands a slight price premium over Sildenafil but offers greater dosing flexibility.
Quality considerations when selecting a Tadalafil product include manufacturing standards, bioavailability consistency, and packaging integrity. Patients should be advised to obtain medications from licensed pharmacies rather than unregulated online sources, as counterfeit products represent a significant public health concern in this therapeutic category.
9. Frequently Asked Questions (FAQ) about Vidalista
What is the recommended course of Vidalista to achieve results?
Most patients experience improvement with the first dose, though optimal results may require 4-8 doses as patients become familiar with the medication’s timing and effects. Daily dosing regimens typically require 5-7 days to reach steady state concentrations.
Can Vidalista be combined with blood pressure medications?
Vidalista can be used with most antihypertensives but may produce additive blood pressure lowering effects. Initial monitoring is recommended, and patients should be advised about potential dizziness or orthostatic symptoms.
How long does Vidalista remain effective?
The plasma half-life is approximately 17.5 hours, with clinical effects typically persisting for 24-36 hours. Individual responses vary based on metabolism, hepatic function, and other factors.
Is Vidalista safe for diabetic patients with erectile dysfunction?
Yes, Vidalista is effective and generally safe in diabetic patients, though efficacy may be slightly reduced in those with significant diabetic neuropathy or vascular disease.
Can Vidalista be taken with alcohol?
Moderate alcohol consumption (1-2 drinks) is generally acceptable, though excessive alcohol may increase the risk of orthostatic hypotension and reduce efficacy.
10. Conclusion: Validity of Vidalista Use in Clinical Practice
The risk-benefit profile of Vidalista supports its position as a first-line pharmacotherapy for erectile dysfunction, with additional potential applications in lower urinary tract symptoms and pulmonary hypertension. The extended duration of action provides unique advantages over shorter-acting alternatives, while maintaining a comparable safety profile. The validity of Vidalista use in clinical practice is well-established through extensive clinical trial data and real-world experience across diverse patient populations.
I remember when we first started prescribing Tadalafil back in 2005 - we were skeptical about this “weekend pill” that supposedly worked for 36 hours. The pharmaceutical reps kept throwing around this “36-hour window” statistic like it was revolutionary, but in practice, I found most of my patients really only got about 24 hours of reliable effect. Still, that was plenty for changing the dynamics of treatment.
There was this one patient - let’s call him Mark, 52-year-old accountant with hypertension well-controlled on amlodipine. He’d tried Sildenafil but hated the timing pressure - said it felt like “scheduling intimacy like a business meeting.” Switched him to Vidalista 10mg and the difference was night and day. His wife actually called the office to thank us - which never happens - said it felt like they’d gotten their relationship back. But then we had the back pain issue around month three - classic Tadalafil side effect - had to drop him down to 5mg daily instead of 10mg as needed. Worked better anyway.
Our urology group actually had significant disagreements about the daily dosing protocol. Johnson was pushing everyone toward daily 5mg, arguing better spontaneity. I was more conservative, worried about cost and long-term effects we didn’t understand yet. Turns out we were both partly right - some patients do brilliantly on daily low dose, others prefer as-needed. The metabolic syndrome patients particularly - the diabetics with A1c around 7.5-8% - they seem to respond better to daily dosing, probably more stable tissue levels.
What surprised me was the BPH effect - we started noticing our ED patients on Tadalafil mentioning they were voiding better at night. Initially thought it was coincidence until we actually tracked IPSS scores retrospectively. The improvement in urinary symptoms was sometimes more significant than the sexual function benefits, especially in our older patients with moderate LUTS.
The failed insight for me was thinking the longer half-life would mean more side effects. Actually found the opposite - patients reported fewer “drug effect” sensations compared to Sildenafil. One guy described it as “I don’t feel like I’m on anything, I just work when I want to.” That psychological component is huge in ED treatment that we often underestimate.
Longitudinal follow-up has been revealing too. Got probably 30-40 patients who’ve been on this for 5+ years now. Efficacy seems maintained if anything improves slightly over first year, maybe as psychological barriers diminish. Safety profile holding up - no unexpected cardiovascular signals, though we did have one patient develop NAION after 3 years, but he had all the risk factors anyway.
Latest thing we’re seeing is combination therapy - low dose Tadalafil daily plus topical alprostadil as needed for refractory cases. Small numbers but promising. Medicine keeps evolving - what we thought we knew about PDE5 inhibitors ten years ago barely scratches the surface now.